https://www.pharmanow.live/latest-news/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations 2026-10-12T22:31:07+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Dr. Reddy's FTO-11 Plant Receives Two FDA Form 483 Observations After Andhra Pradesh Inspection Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2e9916f6-5496-46b5-8b26-32e11f9dca6c/8d4337f5-0b88-475f-a972-a2268f76ebc1.png https://www.pharmanow.live/latest-news/cadila-pharmaceuticals-appoints-nirav-gandhi-president 2026-10-12T22:30:21+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Cadila Pharmaceuticals Appoints Nirav Gandhi as President Amid US Market Push Cadila https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2e9916f6-5496-46b5-8b26-32e11f9dca6c/23157708-29fb-4456-b1b4-10afe3e61d70.png https://www.pharmanow.live/latest-news/fda-updates-phase-1-ind-faq-clinical-hold-nonclinical-data 2026-10-12T22:31:55+05:30 Pharma Now en 2026-10-10T00:00:00+05:30 FDA Updates Phase 1 IND FAQ, Clarifying Clinical Hold Triggers and Nonclinical Data Requirements FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7a59eada-8580-4e8f-97f9-5abbff3574b8/ff8a6a78-6b36-4d5a-abc6-06715e76a749.png https://www.pharmanow.live/latest-news/fda-approves-hovilpri-pritelivir-immunocompromised-hsv-lesions 2026-10-12T22:28:49+05:30 Pharma Now en 2026-10-10T00:00:00+05:30 FDA Approves Hovilpri for Immunocompromised Adults with Treatment-Resistant HSV Lesions FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7a59eada-8580-4e8f-97f9-5abbff3574b8/aab7cd4a-129e-4cf7-a728-d64627c9191a.png